Bleakley Financial Group LLC Purchases 13,586 Shares of Nutrien Ltd. $NTR

Bleakley Financial Group LLC boosted its holdings in Nutrien Ltd. (NYSE:NTRFree Report) by 38.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 49,328 shares of the company’s stock after buying an additional 13,586 shares during the quarter. Bleakley Financial Group LLC’s holdings in Nutrien were worth $2,896,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in NTR. Semanteon Capital Management LP bought a new position in Nutrien during the 3rd quarter worth $566,000. Lansforsakringar Fondforvaltning AB publ increased its stake in shares of Nutrien by 0.6% in the third quarter. Lansforsakringar Fondforvaltning AB publ now owns 104,852 shares of the company’s stock valued at $6,159,000 after buying an additional 647 shares during the period. Princeton Capital Management LLC bought a new position in shares of Nutrien during the third quarter worth about $312,000. Hillsdale Investment Management Inc. lifted its stake in shares of Nutrien by 219,825.0% in the third quarter. Hillsdale Investment Management Inc. now owns 131,955 shares of the company’s stock worth $7,747,000 after acquiring an additional 131,895 shares during the period. Finally, AMG National Trust Bank boosted its holdings in Nutrien by 4.0% in the third quarter. AMG National Trust Bank now owns 4,986 shares of the company’s stock valued at $293,000 after acquiring an additional 193 shares during the last quarter. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Stock Up 1.0%

Nutrien stock opened at $71.89 on Tuesday. The company has a market capitalization of $34.61 billion, a PE ratio of 15.43 and a beta of 0.73. Nutrien Ltd. has a 12-month low of $45.78 and a 12-month high of $73.55. The firm’s fifty day moving average is $66.43 and its 200 day moving average is $60.80. The company has a quick ratio of 0.70, a current ratio of 1.34 and a debt-to-equity ratio of 0.37.

Nutrien (NYSE:NTRGet Free Report) last posted its quarterly earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share for the quarter, missing the consensus estimate of $0.87 by ($0.04). Nutrien had a net margin of 8.43% and a return on equity of 8.41%. The company had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same period last year, the firm posted $0.31 earnings per share. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. As a group, sell-side analysts predict that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.

Nutrien Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.55 per share. This is an increase from Nutrien’s previous quarterly dividend of $0.55. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.20 dividend on an annualized basis and a yield of 3.1%. Nutrien’s dividend payout ratio (DPR) is currently 46.78%.

Key Stories Impacting Nutrien

Here are the key news stories impacting Nutrien this week:

  • Positive Sentiment: Several firms raised price targets on NTR (new targets include $85, $78, $77 and $74), signaling upward revisions to analyst outlooks that can support buying interest. Price Target $85 Price Target $78 Price Target $77 Price Target $74
  • Positive Sentiment: Analysis highlights attractive valuation after Nutrien’s strong results, dividend increase and ongoing buybacks — factors that support shareholder returns and can justify a higher multiple. Valuation & Dividend/Buybacks
  • Neutral Sentiment: A Zacks piece examines whether value investors should buy NTR, focusing on earnings-estimate trends and the Zacks Rank methodology — useful context but not an immediate catalyst. Zacks Analysis
  • Negative Sentiment: BNP Paribas Exane downgraded Nutrien from “outperform” to “neutral,” citing rising pressure on nitrogen prices — a direct earnings risk for Nutrien’s fertilizer segment and a likely headwind for the stock. BNP Paribas Downgrade
  • Negative Sentiment: Market summaries (e.g., Finviz) echoed the downgrade note, increasing visibility of the bearish analyst stance and potentially amplifying short-term selling pressure. Finviz Summary

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. BMO Capital Markets raised their price target on shares of Nutrien from $75.00 to $85.00 and gave the stock an “outperform” rating in a report on Friday. Wall Street Zen upgraded shares of Nutrien from a “hold” rating to a “buy” rating in a research report on Saturday, January 31st. Morgan Stanley raised shares of Nutrien from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $70.00 to $77.00 in a research note on Wednesday, January 14th. Mizuho boosted their target price on shares of Nutrien from $65.00 to $68.00 and gave the company a “neutral” rating in a report on Friday, January 16th. Finally, Bank of America upped their price target on shares of Nutrien from $64.00 to $71.00 and gave the company a “neutral” rating in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Nutrien has a consensus rating of “Hold” and a consensus target price of $71.17.

Get Our Latest Stock Report on NTR

Nutrien Company Profile

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Recommended Stories

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.